We apologize, but this video has failed to load. Try refreshing your browser, or tap here to see other videos from our team. PSC Partners Announces the First Patient Enrolled Into the WIND-PSC Study, ...
TEL AVIV, Israel, Nov. 20, 2023 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, metabolic and fibrotic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback